Bioventus (BVS) Enterprise Value (2020 - 2025)
Bioventus' Enterprise Value history spans 6 years, with the latest figure at -$6.9 million for Q4 2025.
- For Q4 2025, Enterprise Value fell 76.01% year-over-year to -$6.9 million; the TTM value through Dec 2025 reached -$6.9 million, down 76.01%, while the annual FY2025 figure was -$6.9 million, 76.01% down from the prior year.
- Enterprise Value reached -$6.9 million in Q4 2025 per BVS's latest filing, down from -$1.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $91.5 million in Q4 2021 to a low of -$62.3 million in Q3 2021.
- Average Enterprise Value over 5 years is $6.9 million, with a median of $6.6 million recorded in 2024.
- Peak YoY movement for Enterprise Value: surged 1516.68% in 2023, then crashed 137.09% in 2024.
- A 5-year view of Enterprise Value shows it stood at $91.5 million in 2021, then crashed by 37.93% to $56.8 million in 2022, then plummeted by 81.39% to $10.6 million in 2023, then plummeted by 137.09% to -$3.9 million in 2024, then plummeted by 76.01% to -$6.9 million in 2025.
- Per Business Quant, the three most recent readings for BVS's Enterprise Value are -$6.9 million (Q4 2025), -$1.0 million (Q3 2025), and $7.1 million (Q2 2025).